WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LPTX past revenue growth

How has LPTX's revenue growth performed historically?
Company
N/A
Industry
148.64%
Market
17.33%
LPTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LPTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

LPTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$81.4M
Current Profit Margin
0%

LPTX Return on Equity

Current Company
-133.2%
Current Industry
-63.5%
Current Market
188%
LPTX's Return on Equity (-133.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LPTX announces earnings.

LPTX Return on Assets

Current Company
-90.9%
Current Industry
2.9%
LPTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LPTX Return on Capital Employed

Current Company
-135.37%
Current Industry
19.5%
LPTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LPTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LPTX$0.00-$81.40M-$81.41M-100.00%N/A
QTTB$1.16M-$110.32M-$112.96M-26.32%N/A
AFMD$8.99M-$114.03M-$115.15M-19.55%N/A
CMRX$324.00k-$82.09M-$82.10M-46.24%N/A
ALRN$0.00-$15.61M-$15.73MN/AN/A
View Top Biotech Stocks

LPTX earnings dates

Next earnings date
May 13, 2024

Leap Therapeutics Earnings & Revenue FAQ

What were LPTX's earnings last quarter?

On Invalid Date, Leap Therapeutics (NASDAQ: LPTX) reported Q4 2023 earnings per share (EPS) of -$0.20, up 81.31% year over year. Total Leap Therapeutics earnings for the quarter were -$12.47 million. In the same quarter last year, Leap Therapeutics's earnings per share (EPS) was -$1.07.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.

What was LPTX's earnings growth in the past year?

As of Q2 2024, Leap Therapeutics's earnings has grown year over year. Leap Therapeutics's earnings in the past year totalled -$81.41 million.

What is LPTX's earnings date?

Leap Therapeutics's earnings date is Invalid Date. Add LPTX to your watchlist to be reminded of LPTX's next earnings announcement.

What was LPTX's revenue last quarter?

On Invalid Date, Leap Therapeutics (NASDAQ: LPTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Leap Therapeutics's revenue was $0.00.

What was LPTX's revenue growth in the past year?

As of Q2 2024, Leap Therapeutics's revenue has grown null year over year. Leap Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.